Literature DB >> 21668866

Production of ROS by photosensitized anthracene under sunlight and UV-R at ambient environmental intensities.

Syed Faiz Mujtaba1, Ashish Dwivedi, Mohana Krishna Reddy Mudiam, Daoud Ali, Neera Yadav, Ratan Singh Ray.   

Abstract

The aim of this study was to analyze the photostability and phototoxicity mechanism of anthracene (ANT) in a human skin epidermal cell line (HaCaT) at ambient environmental intensities of sunlight/UV-R (UV-A and UV-B). Photomodification of ANT under sunlight/UV-R exposure produced two photoproducts, anthrone and 9,10 anthracenedione. Generation of (1)O(2), O(2)(•-) and (•)OH was measured under UV-R/sunlight exposure. Involvement of reactive oxygen species (ROS) was further substantiated by their quenching with free radical quenchers. Photodegradation of 2-deoxyguanosine and linoleic acid peroxidation showed that ROS were mainly responsible for ANT phototoxicity. ANT generates significant amount of intracellular ROS in cell line. Maximum cell viability (85%) was reduced under sunlight exposure (30 min). Results of MTT assay accord NRU assay. ANT (0.01 μg mL(-1)) induced cell-cycle arrest at G1 phase. RT-PCR demonstrated constitutive inducible mRNA expression of CYP 1A1 and 1B1 genes. Photosensitive ANT upregulates CYP 1A1 (2.2-folds) and 1B1 (4.1-folds) genes. Thus, the study suggests that ROS and DNA damage were mainly responsible for ANT phototoxicity. ANT exposure may be deleterious to human health at ambient environmental intensities reaching the earth's surface through sunlight.
© 2011 The Authors. Photochemistry and Photobiology © 2011 The American Society of Photobiology.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21668866     DOI: 10.1111/j.1751-1097.2011.00955.x

Source DB:  PubMed          Journal:  Photochem Photobiol        ISSN: 0031-8655            Impact factor:   3.421


  1 in total

1.  9-phenyl acridine photosensitizes A375 cells to UVA radiation.

Authors:  Surajit Hansda; Gargi Ghosh; Rita Ghosh
Journal:  Heliyon       Date:  2020-09-03
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.